Last 390.00 GBp
Change Today -7.50 / -1.89%
Volume 232.9K
ABC On Other Exchanges
As of 11:35 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

abcam plc (ABC) Snapshot

394.75 GBp
Previous Close
397.50 GBp
Day High
395.50 GBp
Day Low
384.00 GBp
52 Week High
01/31/14 - 533.50 GBp
52 Week Low
04/8/14 - 346.00 GBp
Market Cap
Average Volume 10 Days
0.17 GBp
Shares Outstanding
8.03 GBp
Dividend Yield
Current Stock Chart for ABCAM PLC (ABC)

Related News

No related news articles were found.

abcam plc (ABC) Related Businessweek News

No Related Businessweek News Found

abcam plc (ABC) Details

Abcam plc engages in the production and distribution of antibodies and related protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, tools and reagents, and immunoassays. Its products are used in the areas of cancer, cardiovascular, cell biology, epigenetics and nuclear signaling, developmental biology, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company sells its products primarily through the Internet. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.

700 Employees
Last Reported Date: 03/4/14
Founded in 1998

abcam plc (ABC) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: 456.0K GBP
Chief Financial Officer, Company Secretary an...
Total Annual Compensation: 384.0K GBP
Chief Operating Officer and Director
Total Annual Compensation: 426.0K GBP
Compensation as of Fiscal Year 2013.

abcam plc (ABC) Key Developments

Abcam Plc Provides Earnings Guidance for the Financial Year Ended June 30, 2014

Abcam plc provided earnings guidance for the financial year ended June 30, 2014. For the year, the company expects adjusted profit before tax to be slightly higher than consensus expectation. The full year underlying catalogue revenue growth on a constant currency basis is expected to be 10.0% (6.0% on a reported basis). In total, Group revenue growth at underlying constant currency for the year was 8.6% (4.7% on a reported basis). The company anticipates that gross margins for the year will be broadly in line with those reported at the interim stage, as the higher margins from the growing portfolio of own-manufactured products were offset by the rapidly growing sales of non-primary antibody products, expansion into new geographies and the impact of exchange rate movements.

Abcam plc Appoints Murray Hennessy as Chairman Replacing Mike Redmond

Abcam plc announced that, after five years as its chairman, Mike Redmond has decided to step down from the board following the annual general meeting, which will be held later this year. He will be succeeded as chairman by Murray Hennessy, who has served as a non-executive director at the company for the past three years.

Abcam plc Appoints Lady Louise Patten as Non-Executive Director and Chair of the Remuneration Committe

Abcam plc announced the appointment of Lady Louise Patten as a Non-Executive Director of the company and as Chair of the Remuneration Committee with immediate effect. Louise brings extensive board level and corporate governance experience, having served on quoted company boards for more than 20 years as a non-executive director, senior independent director, remuneration committee chair and company chair at Marks & Spencer plc, GUS plc and Hilton Group plc. Louise is currently a non-executive director of the FTSE-250 property group Intu Properties plc. She is also a senior adviser at the management consultancy Bain & Company and a non-executive director at the privately held risk consultancy Control Risks Group, where she chairs the audit committee.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABC:LN 390.00 GBp -7.50

ABC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Affymetrix Inc $8.39 USD -0.21
Becton Dickinson and Co $116.08 USD -0.16
Techne Corp $93.10 USD -0.22
View Industry Companies

Industry Analysis


Industry Average

Valuation ABC Industry Range
Price/Earnings 23.9x
Price/Sales 6.4x
Price/Book 4.7x
Price/Cash Flow 23.9x
TEV/Sales 6.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABCAM PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at